Article Information
History
- September 21, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Luis Patricio Maskin, MD1,2,
- Ignacio Bonelli, MD3,
- Gabriel Leonardo Olarte, MD4,
- Fernando Palizas Jr., MD5,
- Agostina E Velo, MD1,3,
- María Fernanda Lurbet, MD1,3,
- Pablo Lovazzano, PT3,
- Sophia Kotsias, MD1,
- Shiry Attie, MD3,
- Ignacio Lopez Saubidet, MD3,
- Natalio D Baredes, MD4,
- Mariano Setten, PT1 and
- Pablo Oscar Rodriguez, MD, PhD1,2,*
- 1Intensive Care Unit, Hospital Universitario Sede Pombo (Instituto Universitario CEMIC, Centro de Educación Médica e Investigaciones Clínicas), Buenos Aires, Argentina
- 2Pulmonary Section, CEMIC, Buenos Aires, Argentina
- 3Intensive Care Unit, Hospital Universitario Sede Saavedra (Instituto Universitario CEMIC), Buenos Aires, Argentina
- 4Intensive Care Unit, Sanatorio Sagrado Corazón, Buenos Aires, Argentina
- 5Intensive Care Unit, Clínica Bazterrica, Buenos Aires, Argentina
- ↵*Corresponding Author: Pablo O. Rodriguez, Unidad de Terapia Intensiva, Hospital Universitario Sede Pombo, CEMIC (Centro de Educación Médica e Investigaciones Clínicas), Av. Cnel. Diaz 2423, Zip Code: 1425, Ciudad Autónoma de Buenos Aires, Argentina, Email: prodriguez{at}cemic.edu.ar
Posted September 21, 2021.
High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-related Acute Respiratory Distress Syndrome: A Multicenter and Randomized Open-label Clinical Trial
